Literature DB >> 10473495

Early trials of angiogenic factors have not targeted patients most at risk of ocular disease.

M McKibbin, D O'Neill.   

Abstract

Entities:  

Mesh:

Year:  1999        PMID: 10473495      PMCID: PMC1116506          DOI: 10.1136/bmj.319.7210.643c

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  4 in total

Review 1.  Therapeutic angiogenesis.

Authors:  T D Henry
Journal:  BMJ       Date:  1999-06-05

Review 2.  Role of vascular permeability factor/vascular endothelial growth factor in eye disease.

Authors:  R O Schlingemann; V W van Hinsbergh
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

3.  Immunolocalisation of the VEGF receptors FLT-1, KDR, and FLT-4 in diabetic retinopathy.

Authors:  G Smith; D McLeod; D Foreman; M Boulton
Journal:  Br J Ophthalmol       Date:  1999-04       Impact factor: 4.638

4.  VEGF localisation in diabetic retinopathy.

Authors:  M Boulton; D Foreman; G Williams; D McLeod
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.